Dolphin Laboratories Ltd
About Dolphin Laboratories Ltd
Data last updated: 26 July 2025
Dolphin Laboratories Ltd was a public limited company based in Kolkata, West Bengal, India. The company has been amalgamated — it was merged with another entity and no longer exists as a separate legal entity. It specialised in instruments and appliances for measuring, a part of the broader healthcare sector. Incorporated on 09 July 1951.
Registered with ROC Kolkata under CIN U33125WB1951PLC024123.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹4 Cr. It was led by directors Chandrakant Ishwarlal Gandhi and Rajesh Chandrakant Gandhi.
Last AGM: 28 September 2006. Financial statements filed for year ended 31 March 2006. Office: 41 Sarat Bose Road Cal-20W.E.F.30.06.2001 P.S.Bhowanipur, Kolkata, West Bengal, India.
As per MCA filings, the company had open charges of ₹34.1 Cr and satisfied charges of ₹6.2 Cr on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address41 Sarat Bose Road Cal-20W.E.F.30.06.2001 P.S.Bhowanipur, Kolkata, West Bengal, India
-
IndustryHealthcare, Instruments And Appliances For Measuring, Checking, Medical Appliances And Instruments, Manufacturing
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Dolphin Laboratories Ltd
Dolphin Laboratories Ltd has one previous CIN (Corporate Identification Number): U33125WB1951PTC024123. The current CIN is U33125WB1951PLC024123, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33125WB1951PLC024123 | Current |
| U33125WB1951PTC024123 | Previous |
Board of Directors of Dolphin Laboratories Ltd
Dolphin Laboratories Ltd is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrakant Ishwarlal Gandhi | Managing Director | 01 Jan 1985 | 41 Years 6 Months | As last reported |
|
Rajesh Chandrakant Gandhi
Also directs:
Almon Healthcare Private Limited, Novamox Vincom Pvt Ltd, Antibiotic Stores Private Limited and 3 more
|
Managing Director | 01 Jan 1985 | 41 Years 6 Months | As last reported |
Financials of Dolphin Laboratories Ltd FY 2006 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Dolphin Laboratories Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2002 | Canara Bank | ₹7.95 Cr | Open |
| 10 Apr 1997 | The Lakshmi Vilas Bank Ltd. | ₹2 Cr | Open |
| 03 Mar 1997 | Industrial Reconstruction Bank of India | ₹4.87 Lakh | Open |
| 06 May 1996 | Industrial Development Bank of India | ₹85 Lakh | Open |
| 06 May 1996 | Industrial Development Bank of India | ₹85 Lakh | Open |
Total charge records: 17 View all charges
Employees and EPFO Compliance at Dolphin Laboratories Ltd
View historical data on people associated with Dolphin Laboratories Ltd, including employment history and EPFO contributions.
Employee Count & EPFO Data of Dolphin Laboratories Ltd
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Dolphin Laboratories Ltd
GSTIN & GST Filing Data of Dolphin Laboratories Ltd
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Dolphin Laboratories Ltd
Credit Ratings, Legal Cases & Regulatory Alerts of Dolphin Laboratories Ltd
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Dolphin Laboratories Ltd
MSME Payment Delays by Dolphin Laboratories Ltd
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Dolphin Laboratories Ltd
Subsidiaries & Group Companies of Dolphin Laboratories Ltd
See the full corporate group — holding company, subsidiaries, associates and joint ventures of Dolphin Laboratories Ltd with ownership details.
MCA Filings & Documents of Dolphin Laboratories Ltd
MCA Filings & Documents of Dolphin Laboratories Ltd
Download official documents filed with the Ministry of Corporate Affairs — from incorporation papers to the latest annual filings.
Recent Activity on Dolphin Laboratories Ltd
Frequently Asked Questions about Dolphin Laboratories Ltd
Dolphin Laboratories Ltd has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Dolphin Laboratories Ltd is a amalgamated public limited company in the healthcare sector based in Kolkata, West Bengal, India. It was incorporated on 09 July 1951 and is registered under CIN U33125WB1951PLC024123. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Dolphin Laboratories Ltd was incorporated on 09 July 1951. Registered with ROC Kolkata.
The current directors of Dolphin Laboratories Ltd are:
The CIN (Corporate Identification Number) of Dolphin Laboratories Ltd is U33125WB1951PLC024123. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Dolphin Laboratories Ltd is healthcare. The company specifically operates in instruments and appliances for measuring.